Tech Company Inital Public Offerings
Argos Therapeutics IPO
Operating out of Durham, Argos Therapeutics is now a public company.
Transaction Overview
Company Name
Announced On
2/7/2014
Transaction Type
IPO
Amount
$45,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4233 Technology Dr.
Durham, NC 27704
USA
Durham, NC 27704
USA
Phone
Website
Email Address
Overview
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Abbey
Chief Financial Officer
Richard Katz
Chief Scientific Officer
Charles Nicolette
VP - Finance
Lori Harrelson
Browse more venture capital transactions:
Prev: 2/7/2014: Docurated venture capital transaction
Next: 2/7/2014: Abe's Market venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs